- Home
- ITOS vs INNV Comparison
ITOS vs INNV Comparison
Compare ITOS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- INNV
- Stock Information
- Founded
- ITOS 2011
- INNV 2007
- Country
- ITOS United States
- INNV United States
- Employees
- ITOS N/A
- INNV N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- INNV Medical/Nursing Services
- Sector
- ITOS Health Care
- INNV Health Care
- Exchange
- ITOS Nasdaq
- INNV Nasdaq
- Market Cap
- ITOS 446.6M
- INNV 485.4M
- IPO Year
- ITOS 2020
- INNV 2021
- Fundamental
- Price
- ITOS $10.11
- INNV $3.43
- Analyst Decision
- ITOS Hold
- INNV Sell
- Analyst Count
- ITOS 6
- INNV 2
- Target Price
- ITOS $10.40
- INNV $5.00
- AVG Volume (30 Days)
- ITOS 1.6M
- INNV 25.7K
- Earning Date
- ITOS 08-06-2025
- INNV 09-09-2025
- Dividend Yield
- ITOS N/A
- INNV N/A
- EPS Growth
- ITOS N/A
- INNV N/A
- EPS
- ITOS N/A
- INNV N/A
- Revenue
- ITOS N/A
- INNV $831,683,000.00
- Revenue This Year
- ITOS N/A
- INNV $13.77
- Revenue Next Year
- ITOS N/A
- INNV $10.12
- P/E Ratio
- ITOS N/A
- INNV N/A
- Revenue Growth
- ITOS 177.89
- INNV 12.19
- 52 Week Low
- ITOS $4.80
- INNV $2.60
- 52 Week High
- ITOS $18.13
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- ITOS 53.14
- INNV 44.63
- Support Level
- ITOS $10.08
- INNV $3.18
- Resistance Level
- ITOS $10.17
- INNV $3.82
- Average True Range (ATR)
- ITOS 0.04
- INNV 0.27
- MACD
- ITOS -0.02
- INNV 0.01
- Stochastic Oscillator
- ITOS 35.29
- INNV 40.82
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.